Annual CFF
-$571.00 K
-$854.00 K-301.77%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual cash flow from financing activities is -$571.00 thousand, with the most recent change of -$854.00 thousand (-301.77%) on December 31, 2023.
- During the last 3 years, LVTX annual CFF has fallen by -$19.54 million (-103.01%).
- LVTX annual CFF is now -100.38% below its all-time high of $151.16 million, reached on December 31, 2021.
Performance
LVTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$368.00 K
-$373.00 K-7460.00%
September 30, 2024
Summary
- As of February 8, 2025, LVTX quarterly cash flow from financing activities is -$368.00 thousand, with the most recent change of -$373.00 thousand (-7460.00%) on September 30, 2024.
- Over the past year, LVTX quarterly CFF has increased by +$114.00 thousand (+23.65%).
- LVTX quarterly CFF is now -100.25% below its all-time high of $148.66 million, reached on March 31, 2021.
Performance
LVTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$198.00 K
+$114.00 K+36.54%
September 30, 2024
Summary
- As of February 8, 2025, LVTX TTM cash flow from financing activities is -$198.00 thousand, with the most recent change of +$114.00 thousand (+36.54%) on September 30, 2024.
- Over the past year, LVTX TTM CFF has increased by +$554.00 thousand (+73.67%).
- LVTX TTM CFF is now -100.12% below its all-time high of $169.21 million, reached on June 30, 2021.
Performance
LVTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LVTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -301.8% | +23.6% | +73.7% |
| 3 y3 years | -103.0% | +23.6% | +73.7% |
| 5 y5 years | -148.6% | +23.6% | +73.7% |
LVTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.4% | at low | -236.3% | +23.6% | -100.1% | +73.7% |
| 5 y | 5-year | -100.4% | at low | -100.3% | +23.6% | -100.1% | +73.7% |
| alltime | all time | -100.4% | at low | -100.3% | +23.6% | -100.1% | +73.7% |
LAVA Therapeutics NV Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$368.00 K(-7460.0%) | -$198.00 K(-36.5%) |
| Jun 2024 | - | $5000.00(>+9900.0%) | -$312.00 K(-34.2%) |
| Mar 2024 | - | $0.00(-100.0%) | -$474.00 K(-17.0%) |
| Dec 2023 | -$571.00 K(-301.8%) | $165.00 K(-134.2%) | -$571.00 K(-24.1%) |
| Sep 2023 | - | -$482.00 K(+207.0%) | -$752.00 K(+171.5%) |
| Jun 2023 | - | -$157.00 K(+61.9%) | -$277.00 K(+229.8%) |
| Mar 2023 | - | -$97.00 K(+506.3%) | -$84.00 K(-129.7%) |
| Dec 2022 | $283.00 K | -$16.00 K(+128.6%) | $283.00 K(+105.1%) |
| Sep 2022 | - | -$7000.00(-119.4%) | $138.00 K(-61.8%) |
| Jun 2022 | - | $36.00 K(-86.7%) | $361.00 K(-87.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $270.00 K(-267.7%) | $2.77 M(-98.2%) |
| Dec 2021 | $151.16 M(+696.9%) | -$161.00 K(-174.5%) | $151.16 M(-0.2%) |
| Sep 2021 | - | $216.00 K(-91.2%) | $151.44 M(-10.5%) |
| Jun 2021 | - | $2.44 M(-98.4%) | $169.21 M(+1.2%) |
| Mar 2021 | - | $148.66 M(>+9900.0%) | $167.22 M(+781.5%) |
| Dec 2020 | $18.97 M(+1513.0%) | $121.90 K(-99.3%) | $18.97 M(+0.6%) |
| Sep 2020 | - | $17.98 M(+3865.2%) | $18.85 M(+2079.1%) |
| Jun 2020 | - | $453.50 K(+10.2%) | $864.90 K(+110.2%) |
| Mar 2020 | - | $411.40 K | $411.40 K |
| Dec 2019 | $1.18 M | - | - |
FAQ
- What is LAVA Therapeutics NV annual cash flow from financing activities?
- What is the all time high annual CFF for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual CFF year-on-year change?
- What is LAVA Therapeutics NV quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly CFF year-on-year change?
- What is LAVA Therapeutics NV TTM cash flow from financing activities?
- What is the all time high TTM CFF for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV TTM CFF year-on-year change?
What is LAVA Therapeutics NV annual cash flow from financing activities?
The current annual CFF of LVTX is -$571.00 K
What is the all time high annual CFF for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual cash flow from financing activities is $151.16 M
What is LAVA Therapeutics NV annual CFF year-on-year change?
Over the past year, LVTX annual cash flow from financing activities has changed by -$854.00 K (-301.77%)
What is LAVA Therapeutics NV quarterly cash flow from financing activities?
The current quarterly CFF of LVTX is -$368.00 K
What is the all time high quarterly CFF for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly cash flow from financing activities is $148.66 M
What is LAVA Therapeutics NV quarterly CFF year-on-year change?
Over the past year, LVTX quarterly cash flow from financing activities has changed by +$114.00 K (+23.65%)
What is LAVA Therapeutics NV TTM cash flow from financing activities?
The current TTM CFF of LVTX is -$198.00 K
What is the all time high TTM CFF for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high TTM cash flow from financing activities is $169.21 M
What is LAVA Therapeutics NV TTM CFF year-on-year change?
Over the past year, LVTX TTM cash flow from financing activities has changed by +$554.00 K (+73.67%)